Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oragenics Inc. Common Stock (NY:OGEN)

0.5508 -0.0217 (-3.79%)
Streaming Delayed Price Updated: 9:37 AM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oragenics Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time for another dive into the biggest pre-market stock movers as we get a start on Thursday trading with the latest news! 
Via InvestorPlace
News headline image
Oragenics Issues Letter to Shareholders
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine Candidate
From Oragenics, Inc.
Via Business Wire
News headline image
Why Bed Bath & Beyond Is Trading Higher By 12%; Here Are 26 Stocks Moving Premarket ↗
Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 25.2% to $0.54 in pre-market trading. Bird secured permit extensions and expanded to new U.S. cities. 
Via Benzinga
News headline image
Oragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive Officer
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific Reports
From Oragenics, Inc
Via Business Wire
News headline image
Oragenics Issues Letter to Shareholders
From Oragenics, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
Oragenics's Earnings: A Preview ↗
Oragenics (AMEX:OGEN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Oragenics will... 
Via Benzinga
News headline image
Oragenics to Participate at the World Vaccine Congress Washington 2022
From Oragenics, Inc.
Via Business Wire
News headline image
Earnings Scheduled For April 27, 2022 ↗
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter. 
Via Benzinga
News headline image
Oragenics Extends Collaboration to Develop Vaccines against Future Variants of Coronaviruses
From Oragenics, Inc.
Via Business Wire
News headline image
68 Biggest Movers From Yesterday ↗
Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares... 
Via Benzinga
News headline image
Executives Buy Around $5.5M Of 3 Penny Stocks ↗
US crude oil futures traded higher on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the... 
Via Benzinga
News headline image
4 Penny Stocks Insiders Are Buying ↗
US crude oil futures traded sharply lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
News headline image
Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics Partners With KBI Biopharma To Produce Material For Its Intranasal COVID-19 Vaccine Candidate ↗
Oragenics Inc (NYSE: OGEN) has entered into an agreement with KBI Biopharma Inc for the process transfer, process optimization, and cGMP manufacturing of... 
Via Benzinga
News headline image
Oragenics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
From Oragenics, Inc.
Via Business Wire
News headline image
5 Stocks Insiders Are Buying Right Now ↗
Several stocks that insiders are buying are worth watching as we enter the new year. This week, that list includes F, CRCT, CHWY and OGEN. 
Via InvestorPlace
News headline image
45 Biggest Movers From Yesterday ↗
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... 
Via Benzinga
News headline image
Nvidia Omniverse: 14 Things for NVDA Stock Investors to Know About the Metaverse Project ↗
Nvidia (NVDA) is bringing its metaverse project, titled Omniverse, out of beta and letting creators take advantage of the service. 
Via InvestorPlace
News headline image
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge ↗
Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93. The U.S. has the... 
Via Benzinga
News headline image
OGEN Stock Alert: The Insider Buying Giving Oragenics Shares Some Oomph Today ↗
Oragenics (OGEN) stock is rising higher on Tuesday following news of massive insider buying at the development-stage company. 
Via InvestorPlace
News headline image
34 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women... 
Via Benzinga
News headline image
23 Stocks Moving in Tuesday's Pre-Market Session ↗
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc... 
Via Benzinga
News headline image
Oragenics Extends Collaboration with NRC Canada For Omicron-Specific Vaccine ↗
Oragenics Inc (NYSE: OGEN) has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) to enable Oragenics to pursue an... 
Via Benzinga
News headline image
Oragenics Extends Collaboration with the National Research Council of Canada to Develop Vaccine against the Omicron Variant
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics to Participate in Virtual Fireside Chat Hosted by Alliance Global Partners
From Oragenics, Inc.
Via Business Wire
News headline image
Oragenics Co-Authors a Publication Describing the Dual Mechanism of Action of Lantibiotics
From Oragenics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.